SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Human & Experimental Toxicology
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Siefkin, A.D.
Right arrow Articles by Corbett, M.G.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Siefkin, A.D.
Right arrow Articles by Corbett, M.G.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Isoniazid Overdose: Pharmacokinetics and Effects of Oral Charcoal in Treatment

A.D. Siefkin

Department of Internal Medicine, Divisions of Pulmonary Medicine, Emergency Medicine, Clinical Toxicology and Sections of Critical Care Medicine, University of California Davis, School of Medicine and University of California, Davis Medical Center (UCDMC), Sacramento, California 98517, USA

T.E. Albertson

Department of Internal Medicine, Divisions of Pulmonary Medicine, Emergency Medicine, Clinical Toxicology and Sections of Critical Care Medicine, University of California Davis, School of Medicine and University of California, Davis Medical Center (UCDMC), Sacramento, California 98517, USA

M.G. Corbett

Department of Internal Medicine, Divisions of Pulmonary Medicine, Emergency Medicine, Clinical Toxicology and Sections of Critical Care Medicine, University of California Davis, School of Medicine and University of California, Davis Medical Center (UCDMC), Sacramento, California 98517, USA

The pharmacokinetics of isoniazid following overdose in two patients is described. One patient was treated with haemodialysis for seizures and persistent coma without obvious immediate clinical improvement. In addition, three volunteer subjects were given isoniazid orally on two separate occasions. Isoniazid elimination pharmacokinetics were determined with and without concominant charcoal. Oral activated charcoal totally prevented the absorption of isoniazid. Current recommendations for treatment of isoniazid overdoses include intravenous pyridoxine (one gram IV pyridoxine for each gram of ingested isoniazid), intravenous diazepam or phenobarbital for continued seizures, and gastric decontamination with lavage and activated charcoal (1 g/kg). Extraordinary measures such as early haemodialysis and haemoperfusion should be reserved for those patients with persistent coma or refractory seizures.

Human & Experimental Toxicology, Vol. 6, No. 6, 497-501 (1987)
DOI: 10.1177/096032718700600608


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?




Advertisement